Evidence map›Paper›PMID 42587803›Full record

ReviewCells2026

Molecular Dynamics of PPAR Nuclear Receptors: From Ligand Binding to Transcriptional Regulation.

Filip Stojceski, Andrea Danani

Abstract readReview
In one paragraph

Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Filip StojceskiSUPSI, IDSIA-Dalle Molle Institute for Artificial Intelligence (USI-SUPSI), Polo Universitario Lugano-Campus Est, Via la Santa 1, 6962 Lugano, Switzerland.ORCID 0000-0001-8778-8395
Andrea DananiSUPSI, IDSIA-Dalle Molle Institute for Artificial Intelligence (USI-SUPSI), Polo Universitario Lugano-Campus Est, Via la Santa 1, 6962 Lugano, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxisome proliferator-activated receptors (PPARα, PPARβ/δ, and PPARγ) are ligand-regulated nuclear receptors that coordinate lipid metabolism, glucose homeostasis, inflammation, adipogenesis, differentiation, and disease-associated transcriptional programs. Although early structural models emphasized ligand-dependent stabilization of helix 12 (H12) and the activation function-2 surface (AF-2), evidence from molecular dynamics (MD) simulations, NMR, HDX-MS, crystallography, mutagenesis, and biochemical assays supports a more complex conformational-ensemble mechanism. Apo and ligand-bound PPARs populate multiple functional substates whose distributions are shifted by ligands, RXR heterodimerization, DNA binding, co-regulators, post-translational modifications, and disease-associated mutations. This review summarizes MD and integrative structural studies of PPAR conformational dynamics, isoform-specific behavior, PPAR-RXR and co-regulator interactions, ligand entry, graded activation, inverse agonism, disease-associated mutations, and phosphorylation-dependent regulation. PPARγ is the most extensively characterized isoform, whereas PPARα and particularly PPARβ/δ remain comparatively underexplored by atomistic and enhanced-sampling approaches. MD is most informative when it extends beyond post-docking pose stability and is integrated with long-timescale sampling, free-energy methods, dynamic-network analysis, and experimental validation. Future simulations should increasingly model biologically realistic assemblies containing RXR, DNA, coactivators or corepressors, disease mutations, and post-translational modifications to connect ligand chemistry with receptor allostery, transcriptional output, and disease biology.

Indexed as

Gene Expression RegulationMolecular Dynamics SimulationPeroxisome Proliferator-Activated ReceptorsTranscription, GeneticAnimalsHumansLigandsProtein BindingLigandsPeroxisome Proliferator-Activated Receptorsallosteryconformational dynamicsmolecular dynamics simulationsperoxisome proliferator-activated receptorsPPAR disease-associated mutationsPPAR modulatorsPPARαPPARβ/δPPARγRXR heterodimer

Identifiers

PMID42587803
PMCPMC13464093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.